Two Phase 3 Trials of Baricitinib for Alopecia Areata.
N Engl J Med. 2022 May 5;386(18):1687-1699. doi: 10.1056/NEJMoa2110343. Epub 2022 Mar 26.
N Engl J Med. 2022.
PMID: 35334197
Clinical Trial.